TEVA

Two Stocks Stand Out In Red-Hot But Volatile Biotech Sector

The enticing if volatile biotechs continue to intrigue investors. Some of the stocks in the fast-growing sector are more alluring than many others, but make no mistake: Biotechs should not be ignored!“Biotech stocks are still in favor with investors for all the right reasons: constant M&A, solid clinical data, regulatory reviews, upcoming scientific conferences, selective stock picking, and technical support,” […]

Teva to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

[Business Wire] – Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the Bank of America Merrill Lynch 2014 Health Care Conference. Eyal Desheh, EVP & CFO will pre moreView todays social media effects on TEVAView the latest stocks trending across Twitter. Click to view dashboardSee who Teva is hiring next, click here to view […]

Teva Announces COPAXONE® Recognized as “Brand of the Year” by Pharmaceutical Executive Magazine

[Business Wire] – Teva Pharmaceutical Industries Ltd., today announced that COPAXONE® , the #1 global therapy for relapsing multiple sclerosis, has been nam moreView todays social media effects on TEVAView the latest stocks trending across Twitter. Click to view dashboardSee who Teva is hiring next, click here to view […]

FDA Approves Teva’s SYNRIBO® (Omacetaxine Mepesuccinate) for Injection for Home Administration

[Business Wire] – Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved SYNRIBO® for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and moreView todays social media effects on TEVAView the latest stocks trending across Twitter. Click to view dashboardSee who Teva is hiring next, click […]

Teva Pharmaceutical’s CEO Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Erez Vigodman Thank you, Kevin. Good morning and good afternoon. I’m delighted to be here today as the CEO of Teva. I could give you the starter speech about what I am doing as a new CEO in developing … moreView todays social media effects on TEVAView the latest stocks trending across Twitter. Click to view […]

Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan

[Business Wire] – Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement allowing Takeda to commercialize Teva’s innovative treat moreView todays social media effects on TEVAView the latest stocks trending across Twitter. Click to view dashboardSee who Teva is hiring next, click here to view […]

AxoGen (AXGN) in Focus: Stock Moves 5.7% Higher

moreView todays social media effects on TEVAView the latest stocks trending across Twitter. Click to view dashboardSee who Teva is hiring next, click here to view […]